Grading antiviral therapy in HCV-infected cirrhotic patients
Chronic hepatitis C (CHC) is a major cause of cirrhosis, end-stage liver disease, and hepatocellular carcinoma. The combination drug regimen of pegylated interferon-alpha (PEG-IFNα) and ribavirin is the approved and well-accepted standard-of-care for CHC. However, CHC patients with decompensated cir...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2013-02-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5240&ClassID=115155828 |